Early arterial stasis during resin-based yttrium-90 radioembolization: incidence and preliminary outcomes

HPB (Oxford). 2014 Apr;16(4):336-41. doi: 10.1111/hpb.12135. Epub 2013 Jun 19.

Abstract

Objectives: This study was conducted to determine the incidence of early stasis in radioembolization using resin yttrium-90 (Y-90) microspheres, to evaluate potential contributing factors, and to review initial imaging outcomes.

Methods: Patients in whom early stasis occurred were compared with those in whom complete delivery was achieved for tumour type and vascularity, tumour : normal liver ratio (T : N ratio) at technetium-99m-macroaggregated albumin (Tc-99m-MAA) angiography, previous intra-arterial therapy, and infusion site (left, right or whole liver). Tumour response was evaluated at 3 months and defined according to whether a partial response and stable disease versus progressive disease were demonstrated.

Results: A total of 71 patients underwent 128 Y-90 infusions in which 26 (20.3%) stasis events occurred. Hypervascular and hypovascular tumours had similar rates of stasis (17.4% versus 27.8%; P = NS). The mean ± standard deviation T : N ratio was 3.03 ± 1.54 and 3.66 ± 2.79 in patients with and without stasis, respectively (P = NS). Stasis occurred in 14 of 81 (17.3%) and 12 of 47 (25.5%) infusions following previous intra-arterial therapy and in therapy-naïve territories, respectively (P = NS). Early stasis occurred in 15 of 41 (36.6%) left, 10 of 65 (15.4%) right and one of 22 (4.5%) whole liver infusions (P < 0.001). Rates of partial response and stable disease were similar in the stasis (88.3%) and non-stasis (76.0%) groups (P = NS).

Conclusions: Early stasis occurred in approximately 20% of infusions with similar incidences in hyper- and hypovascular tumours. Whole-liver therapy reduced the incidence of stasis. Stasis did not appear to affect initial imaging outcomes.

MeSH terms

  • Aged
  • Brachytherapy / adverse effects*
  • Embolization, Therapeutic / adverse effects*
  • Female
  • Humans
  • Infusions, Intra-Arterial
  • Liver Neoplasms / blood supply
  • Liver Neoplasms / pathology
  • Liver Neoplasms / therapy*
  • Male
  • Microspheres
  • Middle Aged
  • Radiopharmaceuticals / administration & dosage
  • Radiopharmaceuticals / adverse effects*
  • Regional Blood Flow
  • Retrospective Studies
  • Risk Factors
  • Time Factors
  • Treatment Outcome
  • Yttrium Radioisotopes / administration & dosage
  • Yttrium Radioisotopes / adverse effects*

Substances

  • Radiopharmaceuticals
  • Yttrium Radioisotopes